Status:
COMPLETED
Investigate the Responsiveness of the Erectile Quality Scale to Vardenafil Flexible Dose vs Placebo in Males With Erectile Dysfunction (ED)
Lead Sponsor:
Bayer
Conditions:
Erectile Dysfunction
Eligibility:
MALE
18-64 years
Phase:
PHASE4
Brief Summary
This study was conducted to evaluate in adult men with erectile dysfunction (often called impotence), the effect of vardenafil HCl on the quality of their erections. Many men experience occasional ere...
Eligibility Criteria
Inclusion
- Males who have had ED for at least six months- Heterosexual relationship.- Males 18 and older.
Exclusion
- Primary hypoactive sexual desire.- History of myocardial infarction, stroke or life-threatening arrhythmia within the prior 6 months.- Stable heterosexual relationship for \> 6 month- Other exclusion criteria apply according to the US Product Information
Key Trial Info
Start Date :
July 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2005
Estimated Enrollment :
219 Patients enrolled
Trial Details
Trial ID
NCT00665340
Start Date
July 1 2004
End Date
January 1 2005
Last Update
October 11 2013
Active Locations (12)
Enter a location and click search to find clinical trials sorted by distance.
1
Phoenix, Arizona, United States, 85023
2
Beverly Hills, California, United States, 90212
3
Laguna Hills, California, United States, 92653
4
Newport Beach, California, United States, 92660